|
1
|
Mínguez B and Lachenmayer A: Diagnostic
and prognostic molecular markers in hepatocellular carcinoma. Dis
Markers. 31:181–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nishida N and Goel A: Genetic and
epigenetic signatures in human hepatocellular carcinoma: a
systematic review. Curr Genomics. 12:130–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olsen SK, Brown RS and Siegel AB:
Hepatocellular carcinoma: review of current treatment with a focus
on targeted molecular therapies. Therap Adv Gastroenterol. 3:55–66.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ng KK, Lo CM, Liu CL, Poon RT, Chan SC and
Fan ST: Survival analysis of patients with transplantable recurrent
hepatocellular carcinoma: implications for salvage liver
transplant. Arch Surg. 143:68–74. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim do Y, Paik YH, Ahn SH, Youn YJ, Choi
JW, Kim JK, Lee KS, Chon CY and Han KH: PIVKA-II is a useful tumor
marker for recurrent hepatocellular carcinoma after surgical
resection. Oncology. 72(Suppl 1): 52–57. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Zhang JB, Qin Y, Wang W, Wei L, et
al: PROX1 promotes hepatocellular carcinoma metastasis by way of
up-regulating hypoxia-inducible factor 1α expression and protein
stability. Hepatology. 58:692–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tahara H, Kay MA, Yasui W and Tahara E:
MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th
Japanese Association for RNA Interference Joint International
Symposium, 30 August 2012, Grand Prince Hotel Hiroshima. Jpn J Clin
Oncol. 43:579–582. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan Q, Loya K, Rani B, Möbus S,
Balakrishnan A, et al: MicroRNA-221 overexpression accelerates
hepatocyte proliferation during liver regeneration. Hepatology.
57:299–310. 2013. View Article : Google Scholar
|
|
10
|
Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao
Y, Li Y, et al: HBx-mediated miR-21 upregulation represses
tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Oncogene. 32:3296–3305. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng Q, Sheng Q, Jiang C, Shu J, et al:
MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by
targeting cyclin-dependent kinase inhibitor 1B. Mol Cell Biochem.
389:187–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu L, Ding GF, He C, Sun L, Jiang Y and
Zhu L: MicroRNA-424 is down-regulated in hepatocellular carcinoma
and suppresses cell migration and invasion through c-Myb. PLoS One.
9:e916612014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alpini G, Glaser SS, Zhang JP, Francis H,
Han Y, Gong J, Stokes A, et al: Regulation of placenta growth
factor by microRNA-125b in hepatocellular cancer. J Hepatol.
55:1339–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Wang Y, Song Y, Fu Z and Yu W:
miR-27a regulates cisplatin resistance and metastasis by targeting
RKIP in human lung adenocarcinoma cells. Mol Cancer. 13:1932014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan Y, Shen Y, Xue L and Fan H: miR-140
suppresses tumor growth and metastasis of non-small cell lung
cancer by targeting insulin-like growth factor 1 receptor. PLoS
One. 8:e736042013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Smirnova L, Gräfe A, Seiler A, Schumacher
S, Nitsch R and Wulczyn FG: Regulation of miRNA expression during
neural cell specification. Eur J Neurosci. 21:1469–1477. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Yan LX, Wu QN, Du ZM, Chen J,
Liao DZ, et al: miR-125b is methylated and functions as a tumor
suppressor by regulating the ETS1 proto-oncogene in human invasion
breast cancer. Cancer Res. 71:3552–3562. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim
JH, et al: MicroRNA expression profiles in serous ovarian
carcinoma. Clin Cancer Res. 14:2690–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scott GK, Goga A, Bhaumik D, Berger CE,
Sullivan CS and Benz CC: Coordinate suppression of ERBB2 and ERBB3
by enforced expression of microRNA miR-125a or miR-125b. J Biol
Chem. 282:1479–1486. 2007. View Article : Google Scholar
|
|
20
|
Li W, Xie L, He X, Li J, Tu K, Wei L, et
al: Diagnostic and prognostic implications of microRNAs in human
hepatocellular carcinoma. Int J Cancer. 123:1616–1622. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu
M, et al: An androgen-regulated miRNA suppresses Bak1 expression
and induces androgen-independent growth of prostate cancer cells.
Proc Natl Acad Sci USA. 104:19983–19988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B,
Korzh V, et al: MicroRNA-125b is a novel negative regulator of p53.
Genes Dev. 23:862–876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang K, Degerny C, Xu M and Yang XJ: YAP,
TAZ, and Yorkie: a conserved family of signal-responsive
transcriptional coregulators in animal development and human
disease. Biochem Cell Biol. 87:77–91. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong JH, Hwang ES, McManus MT, Amsterdam
A, Tian Y, Kalmukova R, et al: TAZ, a transcriptional modulator of
mesenchymal stem cell differentiation. Science. 309:1074–1078.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Varelas X, Sakuma R, Samavarchi-Tehrani P,
Peerani R, et al: TAZ controls Smad nucleocytoplasmic shuttling and
regulates human embryonic stem-cell self-renewal. Nat Cell Biol.
10:837–848. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chan SW, Lim CJ, Guo K, Ng CP, Lee I,
Hunziker W, Zeng Q and Hong W: A role for TAZ in migration,
invasion, and tumorigenesis of breast cancer cells. Cancer Res.
68:2592–2598. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Z, Hao Y, Liu N, et al: TAZ is a
novel oncogene in non-small cell lung cancer. Oncogene.
30:2181–2186. 2011. View Article : Google Scholar : PubMed/NCBI
|
